
Rabmiza D 30mg/20mg Capsule SR
Marketer
Incuity Pharma Pvt. Ltd.
Salt Composition
Domperidone (30mg) + Rabeprazole (20mg)
Overview Rabmiza D 30mg/20mg Capsule SR
Gastroesophageal reflux disease (GERD, or acid reflux) is effectively managed with Rabmiza D 30mg/20mg sustained-release capsules, a dual-action formulation. This medication alleviates symptoms like heartburn, stomach upset, and discomfort by neutralizing stomach acid and facilitating gas expulsion. Administered as directed by your physician, Rabmiza D is taken on an empty stomach; dosage and treatment duration are personalized. Consistent use, as prescribed, is crucial; premature discontinuation may lead to symptom recurrence and condition exacerbation. Inform your doctor of all other medications you are using, as interactions are possible. Common, typically transient side effects include diarrhea, abdominal pain, dry mouth, headache, gas, and fatigue. Report any concerning side effects immediately. Drowsiness and dizziness are potential side effects; refrain from driving or activities requiring alertness until the medication's impact is known. Alcohol consumption should be avoided due to potential increased drowsiness. Lifestyle adjustments, such as consuming cold milk and avoiding stimulants like coffee, tea, spicy foods, and chocolate, can enhance treatment outcomes. Prior to commencing treatment, disclose any kidney or liver conditions, as well as pregnancy, pregnancy plans, or breastfeeding.
Uses of Rabmiza D 30mg/20mg Capsule SR
Managing gastroesophageal reflux and peptic ulcers.
Major Benefits of Rabmiza D 30mg/20mg Capsule SR:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the Rabmiza D 30mg/20mg SR capsule whole; avoid chewing, crushing, or breaking it. Administer on an empty stomach.
Common Side effects of Rabmiza D 30mg/20mg Capsule SR:
- Cough
- Headache
- Diarrhea
- Dizziness
- Inflammation of the nose
- Abdominal pain
- Vomiting
- Weakness
- Nasal congestion (stuffy nose)
- Insomnia (difficulty in sleeping)
- Fundic gland polyps
- Nausea
- Constipation
- Flatulence
- Back pain
- Pharyngitis
How to use Rabmiza D 30mg/20mg Capsule SR:
Consume this medication precisely as your physician directs, adhering to the prescribed dosage and treatment period. Ingest the entire capsule without crushing, chewing, or breaking it. Rabmiza D 30mg/20mg sustained-release capsules should be taken on an empty stomach.
How Rabmiza D 30mg/20mg Capsule SR works:
Rabmiza D 30mg/20mg sustained-release capsules contain Domperidone and Rabeprazole, two active ingredients working synergistically. Domperidone, a gastrointestinal motility stimulant, enhances upper digestive tract movement, facilitating smoother food transit. Rabeprazole, a proton pump inhibitor (PPI), decreases stomach acid production, thereby alleviating acid indigestion and heartburn symptoms.
SAFETY ADVICE
AlcoholCAUTION
Exercise caution when combining Rabmiza D 30mg/20mg SR capsules with alcohol. Seek medical advice before doing so.
PregnancyCONSULT YOUR DOCTOR
Using Rabmiza D 30mg/20mg SR capsules during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against any risks prior to prescribing this medication. Seek medical advice before use.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Rabmiza D 30mg/20mg capsules are likely not safe for breastfeeding mothers. Available human data indicates potential transfer to breast milk, posing a risk to the infant.
DrivingUNSAFE
Taking Rabmiza D 30mg/20mg sustained-release capsules might reduce attentiveness, impair vision, or cause drowsiness and dizziness. Driving should be avoided if these side effects appear.
KidneyCAUTION
Exercise caution when administering Rabmiza D 30mg/20mg SR capsules to individuals with impaired renal function. Dosage modification of Rabmiza D 30mg/20mg SR capsules may be necessary. Physician consultation is advised.
LiverCAUTION
Exercise caution when prescribing Rabmiza D 30mg/20mg SR capsules to individuals with hepatic impairment; dosage modification may be necessary. Consult a physician before administration. Rabmiza D 30mg/20mg SR capsules are contraindicated in patients exhibiting moderate to severe liver dysfunction.
What if you forget to take Rabmiza D 30mg/20mg Capsule SR :
Should you forget to take a Rabmiza D 30mg/20mg sustained-release capsule, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Rabmiza D 30mg/20mg Capsule SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Gastrointestinal system |
